GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS USE IS NOT ASSOCIATED WITH IMMEDIATE WORSE OUTCOMES IN PATIENTS UNDERGOING ERCP: A MULTINATIONAL ANALYSIS | Publicación